Ormeloxifene is a selective estrogen receptor modulator used in the treatment of breast cancer and as a contraceptive. However, during the manufacturing process, impurities may be present in the final product. These impurities can affect the efficacy and safety of the drug. Therefore, it is important to identify and control these impurities to ensure the quality of the drug product. Various analytical techniques are used to detect and quantify ormeloxifene impurities, including chromatography and spectroscopy.
